Background and Purpose-We compared outcome and complications in patients with stroke treated with intravenous thrombolysis (IVT) who could not live alone without help of another person before stroke (dependent patients) versus independent ones. Methods-In a multicenter IVT-register-based cohort study, we compared previously dependent (prestroke modified Rankin Scale score, 3-5) versus independent (prestroke modified Rankin Scale score, 0-2) patients. Outcome measures were poor 3-month outcome (not reaching at least prestroke modified Rankin Scale [dependent patients]; modified Rankin Scale score of 3-6 [independent patients]), death, and symptomatic intracranial hemorrhage. Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (OR [95% confidence interval]) were calculated. Results-Among 7430 IVT-treated patients, 489 (6.6%) were dependent and 6941 (93.4%) were independent. Previous stroke, dementia, heart, and bone diseases were the most common causes of preexisting dependency. Dependent patients were more likely to die (OR unadjusted , 
I
ntravenous thrombolysis (IVT) is efficacious and safe in patients with acute ischemic stroke. 1 However, it is unclear whether this is also true for patients who could not live alone without daily help of another person prior to stroke (ie, modified Rankin Scale score of ≥3).
2 Such patients were not eligible for the large controlled randomized IVT trials including third international stroke trial . 3 In clinical practice, some patients with preexisting dependency receive IVT, 4 whereas others do not. 5 The present study aimed at investigating the impact of preexisting dependency on outcomes and (bleeding) complications in a large population of IVT-treated stroke patients.
Methods
As a joint initiative of 12 European stroke centers, the Thrombolysis in Ischemic Stroke Patients (TriSP) investigators performed a large collaborative clinical cohort study.
All participating centers treated patients with acute ischemic stroke with IVT according to current guidelines (http://www.esostroke.org/eso-stroke/education/guidelines.html).
Data from individual patients were collected with a standardized form with predefined variables as it was done in previous studies. [6] [7] [8] [9] Local study investigators filled in the forms systematically using prospectively ascertained in-hospital intravenous ischemic stroke thrombolysis registries. Completed forms from all centers were compiled in the coordinating center Basel, where the analysis of the pooled data was performed, as done previously. 6, 7 The study was approved by the ethics committee in Basel, Switzerland. The requirement for additional local ethical approval differed between participating centers and was obtained if required.
The following prospectively ascertained variables were used: age, sex, modified Rankin Scale before stroke (prestroke mRS), initial stroke severity as assessed by the National Institutes of Health Stroke Scale score, 10 blood pressure before IVT, onset-to-treatment time, renal function as quantified by the estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration 7 ) and glucose levels in blood serum, vascular risk factors according to predefined criteria, 11 and previous treatment with antithrombotic agents (antiplatelet agents or anticoagulants). Prestroke mRS score had been estimated by the stroke physicians who also indicated and applied IVT. The scores were based on information provided by patients and next-to-kin during the information about benefits and risks of IVT, and all written reports available before IVT. Functional 3-month outcome was assessed with the mRS by using a structured interview at outpatient visits or telephone calls with patients or relatives. There was monitoring for intracranial hemorrhage (ICH) by follow-up computed tomography or magnetic resonance imaging as done in previous research. 6, 7 Each center reported on the period for which they had prospectively collected data on consecutive patients up to November 30, 2014 (Table I in the online-only Data Supplement). All patients with missing prestroke mRS and missing 3-month outcome data were excluded. Preexisting dependency was defined by a prestroke mRS score of 3 to 5, while preexisting independency meant a prestroke mRS score of 0, 1, or 2.
Outcome and complication measures were as follows: (1) poor functional 3-month outcome, defined as 3-month mRS score of 3 to 6 in previously independent patients and a 3-month mRS higher than the prestroke mRS in previously dependent patients as applied in previous research 12 and shown in Figure 1 , (2) death, and (3) symptomatic ICH (sICH) according to criteria of the European Cooperative Acute Stroke Study (ECASS)-II trial.
13

Main Analysis
We investigated the impact of preexisting dependency on outcomes by comparing patients who were dependent on the help of others before stroke (prestroke mRS score, 3-5) with previously independent patients (prestroke mRS score, 0-2; Figure 1 ).
Subgroup Analyses
First, we investigated the impact of different degrees of prestroke dependency on outcomes. Patients who were dependent on the daily help of others before stroke were subdivided in those with complete dependency (ie, prestroke mRS score, [4] [5] and in those patients with partial dependency (ie, prestroke mRS score, 3; Figure 1 ). Second, among survivors at 3 months, we studied the impact of prestroke dependency on functional outcome. Third, in a subset of patients, the causes of preexisting dependency were available from the following centers: Amsterdam, Basel, Berlin, Brescia, and Modena. The diagnosis of comorbidities causing dependency was provided by local investigators and categorized by consensus by three adjudicators (H.G., S.C., S.T.E.).
Statistical Analyses
Statistical analysis was performed using SPSS (version 19.0 for Windows; SPSS Inc, Chicago, IL).
For the main analysis, patient's prestroke mRS was divided into 2 groups: prestroke mRS score of 0 to 2 and prestroke mRS score of 3 to 5. Prestroke mRS score of 0 to 2 served as the reference group. For subgroup analyses, previously dependent patients were subdivided into prestroke mRS score of 3 (partial dependency) and mRS score of 4 to 5 (complete dependency). Data were summarized as median (±interquartile range). We used Fisher exact test, χ 2 test for categorical variables and the Mann-Whitney U test for continuous variables, where appropriate. The association between prestroke mRS and outcome was estimated by calculating odds ratios (OR) with 95% confidence intervals (95% CIs), using binary logistic regression models. In the multivariable analysis, the models were adjusted for all variables with P<0.1 in the univariable analyses.
Results
Baseline Characteristics
Data were eligible for analysis in 7430 (89.2%) of the 8327 IVT-treated patients. Six-hundred fifty-nine (7.9%) patients were excluded from analyses because of missing prestroke mRS data and 238 (2.9%) because of missing 3-month outcome data. Among study patients, 6941 (93.4%) were previously independent and 489 (6.6%) dependent before stroke. The latter included 347 patients with prestroke mRS score of 3, 132 with prestroke mRS score of 4, and 10 patients with prestroke mRS score of 5. Previously dependent patients were older, more often women, had more severe strokes, more often vascular risk factors (except smoking and hypercholesterolemia), and were more often on antithrombotic medication than previously independent patients ( Table 1 ). The distribution of 3-month mRS depending on prestroke mRS is presented in Figure 2A .
In 5 centers, data on causes of preexisting dependency were available. In 193 patients, preexisting dependency was caused by a single disease in 133 (68.9%) patients and multifactorial in 60 (31.1%) patients. Causes of preexisting dependency included dementia (n=88; 45.6%), previous strokes (n=32; 16.6%), heart diseases (n=32; 16.6%), and degenerative or traumatic bone diseases (n=38; 19.7%). Details are shown in Table II in the online-only Data Supplement.
Logistic Regression Analyses
In univariable analyses, poor outcome (60.5% versus 39.6%) and death (38.7% versus 12.2%) occurred significantly more often in patients with previous dependency than in independent patients. sICH (4.8% versus 4.5%) occurred equally
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Different Degrees of Dependency
Patients with complete dependency before stroke (prestroke mRS score, 4 or 5) had a higher median National Institutes of Health Stroke Scale on admission than patients with partial dependency (prestroke mRS score, 3; Table 1 ). They died significantly more often within 3 months after IVT (48.6% versus 34.6%), whereas all other outcome events did not differ significantly between both groups (Table 2; Figure 2B ). In regression analyses, the increased likelihood of death for those with complete dependency was similar with and without adjustment (OR unadjusted , GFR indicates glomerular filtration rate; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; prestroke completely dependent, prestroke mRS score of 4 to 5; prestroke dependent, prestroke mRS score of 3 to 5; prestroke independent, prestroke mRS score of 0 to 2; and prestroke partially dependent, prestroke mRS score of 3. 
Outcome of Survivors
Among survivors, the proportion of patients with poor functional outcome did not differ significantly between previously dependent and independent patients (35.7% versus 31.3%; OR unadjusted , 1.22; 95% CI, 0.96-1.55; P=0.112). However, after adjustment for age and National Institutes of Health Stroke Scale, the likelihood for poor outcome was lower in previously dependent patients (OR adjusted , 0.64; 95% CI, 0.49-0.84; P=0.001).
Discussion
This exploratory multicenter study addressed the impact of preexisting dependency on outcome and complications in IVTtreated stroke patients. We observed the following key findings: (1) previously dependent patients had a higher 3-month mortality rate than previously independent patients. (2) The frequency of symptomatic ICH was similar in both groups. Among survivors, previously dependent patients had higher odds to avoid poor 3-month outcome than independent ones if age and stroke severity were taken into account. (4) Causes of preexisting dependency were multifactorial in one third of patients and mostly caused by dementia, previous stroke, heart disease, and degenerative or traumatic bone diseases.
In our cohort, ≈40% of the IVT-treated patients with preexisting disability had died within 3 months. This rate is comparable with previous observations in smaller studies, in which 7 of 14 patients, and 49% among 171 patients with previous dependency (applying the same definition as in our cohort) died within 3 months. 4, 12 As a refinement, our data allowed an estimate of the mortality risk. After adjustment for confounding variables, being previously dependent meant that the likelihood was twice as high to die within the next 3 months after IVT when compared with previously independent patients treated with IVT.
In a non-IVT-treated stroke population, preexisting disability was independently associated with death with an OR of 2.1 (95% CI, 1.4-3.2), 14 virtually identical to that in our IVTtreated patients (OR adjusted , 2.19; 95% CI, 1.70-2.84).
The observed higher mortality is not explained by an excess of bleeds, as sICH occurred as often in dependent as in independent patients. Possible explanations for the higher 3-month mortality among previously dependent patients may include (1) a higher susceptibility for complications other than sICH, (2) worsening of preexisting comorbid diseases triggered by the stroke, (3) a higher disease burden caused by preexisting comorbidities in such patients, and (4) withdrawal of care according to patient's preferences.
Furthermore, and as a novelty, our data showed that the mortality risk increased with increasing degree of preexisting dependency. For patients with preexisting complete dependency, the odds for being dead at 3 months were ≈10% Figure 2 . Distribution of 3-mo modified Rankin Scale (mRS) depending on prestroke mRS (A) and frequency of symptomatic intracranial hemorrhage, death or poor outcome at 3 mo (B)-stratified to the dependency level before stroke. Data are presented in percent of all intravenous thrombolysis-treated stroke patients of each group. 3M-mRS indicates mRS at 3 mo; poor outcome, not reaching at least prestroke mRS in previously dependent patients (mRS score of 3 to 6 in previously independent patients); prestroke independent, prestroke mRS score of 0 to 2; prestroke dependent, prestroke mRS score of 3 to 5; prestroke partially dependent, prestroke mRS score of 3; prestroke completely dependent, prestroke mRS score of 4 to 5; and sICH, symptomatic intracranial hemorrhage (European Cooperative Acute Stroke Study [ECASS] II definition). Patients with previous dependency more often had poor functional outcome than previously independent patients (60.5% versus 39.6%). However, after adjustment for potential confounders preexisting dependency did not predict poor outcome independently (OR adjusted , 0.95; 95% CI, ). This observation is unpreceded and differed from the result of a subgroup analysis in another study, suggesting a higher risk of poor outcome in patients with preexisting dependency (OR adjusted , 1.70; 0.99-2.94). 12 Unexpectedly, among survivors, previously dependent patients had better odds to avoid poor outcome than independent patients in our cohort if age and stroke severity were taken into account. We can only speculate on possible reasons: (1) our definition of poor outcome (which we adopted from a previous study 12 ) differed between both groups and may have favored the previously dependent patients. In detail, among survivors, dependent patients with a prestroke mRS score of 3 can only move to an mRS score of 4 or 5, patients with a GFR indicates glomerular filtration rate; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; poor outcome, not reaching at least prestroke mRS in previously dependent patients (mRS score of 3 to 6 in previously independent patients); prestroke completely dependent, prestroke mRS score of 4 to 5; prestroke dependent, prestroke mRS score of 3 to 5; prestroke independent, prestroke mRS score of 0 to 2; prestroke partially dependent, prestroke mRS score of 3; and sICH, symptomatic intracranial hemorrhage (European Cooperative Acute Stroke Study [ECASS] II definition). Values represent odds ratio (95% confidence interval); P value. mRS indicates modified Rankin Scale; poor outcome, not reaching at least prestroke mRS in previously dependent patients (mRS score of 3 to 6 in previously independent patients); prestroke completely dependent, prestroke mRS score of 4 to 5; prestroke dependent, prestroke mRS score of 3 of 5; prestroke independent, prestroke mRS score of 0 to 2; prestroke partially dependent, prestroke mRS score of 3; and sICH, symptomatic intracranial hemorrhage (European Cooperative Acute Stroke Study [ECASS] II definition).
*Adjusted for age, National Institutes of Health Stroke Scale only.
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http://stroke.ahajournals.org/ Downloaded from prestroke mRS score of 4 only to mRS score of 5, and among survivors, patients with a prestroke mRS score of 5 cannot have a poor outcome. In contrast, previously independent have a greater capacity to have poor outcome (mRS score, [3] [4] [5] . (2) The functional worsening caused by the current stroke (measured with the mRS) might be less severe in patients with an existing impairment of capability in activities of daily living as in patients without previous deficits. Thus, we urge to a cautious interpretation of this observation. (3) Theoretically, one might hypothesize that some causes of preexisting dependency (eg, depression, Parkinson disease, and bone fractures) might have improved during the 3-month follow-up with rehabilitative and medical therapy. In previous research, the causes for preexisting disability or dependency were not addressed. 4, 12 In our cohort, causes were multiple in about one third of patients. Dementia, sequela from previous stroke, heart diseases, and degenerative or traumatic bone diseases were the most common causes for preexisting dependency. For dementia, 2 recent observational studies showed no significant differences in (in-hospital) mortality and occurrence of ICH between IVT-treated stroke patients with and without dementia. 15, 16 In turn, dementia requiring custodial care has been a reported exclusion criteria for IVT in some centers. 17 For previous stroke, a large casecontrol study showed that such patients seem to benefit from IVT when compared with those who were not IVT treated. 18 Thus, taking into account the aforementioned observations and our findings, it might be questionable to withhold IVT from acute stroke patients with dementia or sequela of previous strokes even if these comorbidities have had caused dependency before the current stroke.
Strengths of this study include (1) the relatively large sample size, which (a) reduces the risk of chance findings and (b) allows adjustment for (potentially) confounding variables; (2) a low number of missing data on 3-month outcome (3.1%), which reduces the risk of bias, and (3) the systematic and standardized assessment of data, which were collected prospectively uninfluenced by the current research question.
Nevertheless, we are aware of several limitations: (1) data came from registries that were not monitored and nonrandomized. Furthermore, the low frequency of patients with preexisting dependency (ie, 6.6%) in our IVT-cohort suggests a selection bias. We do not know how many dependent patients were not treated with IVT. More importantly, we do not know how dependent patients treated with IVT differed from those who did not receive IVT. However, it may be assumed that preferentially those dependent patients got IVT, who had a favorable prognosis. Thus, the outcomes detected in our IVT-treated sample of dependent patients should not be considered representative of all dependent patients who might be otherwise eligible for IVT. In addition, in ≈8% of the patients, information about prestroke mRS was missing. Thus, because of these limitations, we urge to a cautious interpretation of our results. (2) We compared previously dependent with previously independent patients who both had received IVT. To answer the question whether IVT is effective and safe in patients with preexisting dependency, a randomized controlled trial comparing IVT versus non-IVT in such patients would be required. At least our results indicate that such a trial would be ethically justified. (3) Providing outcome data separately for the subset of survivors involves the risk that outcomes might be perceived inappropriately good. In clinical practice, patients (and relatives) often do fear to be alive but dependent more than to die after stroke. (4) The assessment of the prestroke mRS is challenging, and its reliability is limited. 19 Furthermore, the raters of the mRS at 3 months were not blinded to the prestroke mRS, which may have had influenced their rating. (5) The meaning of the causes of preexisting dependency could not be addressed sufficiently because such data were only available for a subgroup of patients.
Conclusions
The present study revealed that patients with IVT-treated stroke who were dependent on the daily help of others before stroke carry a higher mortality risk than previously independent patients. However, the risk of sICH was not different between these 2 groups, suggesting that IVT is apparently safe in this group. Among survivors, the adjusted odds to avoid poor outcome were even higher in previously dependent patients. Thus, withholding IVT in previously dependent patients might not be justified.
